Natasha Kekre

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

Sattva S. Neelapu, Michael Dickinson, Javier Muñoz et al. · Nature Medicine · 2022 · 283 citations · Full text

Medicine, Hematology, Oncology +17

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Mahasweta Gooptu, Rizwan Romee, Andrew St. Martin et al. · Blood · 2021 · 164 citations · Full text

Medicine, Hematology, Immunology +12

Pancratistatin: A natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis

Andrew J. McLachlan, Natasha Kekre, James McNulty et al. · APOPTOSIS · 2005 · 154 citations

Life Sciences, Oncology, Pharmacology +14

Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells

Natasha Kekre, Carly Griffin, James McNulty et al. · Cancer Chemotherapy and Pharmacology · 2005 · 112 citations

Life Sciences, Cell Biology, Oncology +11